ArticleTherapeutic advances in hematology2021

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.

María Poza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.